P367: The impact of modulator therapies on lipids and fatty acids profiles in children and adolescents with cystic fibrosis

P367: The impact of modulator therapies on lipids and fatty acids profiles in children and adolescents with cystic fibrosis

Bibliographic Details
Main Authors:	Tatiana Yuzyuk, Catherine McDonald, Irene De Biase, Lisa Johnson, Yuan Ji, Nicole Williams, Suzanne Meihls, Fadi Asfour
Format:	Article
Language:	English
Published:	Elsevier 2023-01-01
Series:	Genetics in Medicine Open
Online Access:	http://www.sciencedirect.com/science/article/pii/S2949774423003953

Similar Items

Mechanisms of lipid malabsorption in Cystic Fibrosis: the impact of essential fatty acids deficiency
by: Peretti N, et al.
Published: (2005-05-01)

Cystic Fibrosis Defective Response to Infection Involves Autophagy and Lipid Metabolism
by: Alessandra Mingione, et al.
Published: (2020-08-01)

Biomarkers of inflammation in infants with cystic fibrosis
by: Theresa A. Laguna, et al.
Published: (2018-01-01)

Correction: Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Allelic Variants Relate to Shifts in Faecal Microbiota of Cystic Fibrosis Patients.
by: Serena Schippa, et al.
Published: (2013-01-01)

Benchmarking AlphaMissense pathogenicity predictions against cystic fibrosis variants
by: Eli Fritz McDonald, et al.
Published: (2024-01-01)

Benchmarking AlphaMissense pathogenicity predictions against cystic fibrosis variants.
by: Eli Fritz McDonald, et al.
Published: (2024-01-01)

Future Comorbidities in an Aging Cystic Fibrosis Population
by: Javier Humberto Ticona, et al.
Published: (2023-05-01)

EKC 367 - PLANT SAFETY
by: PPKK, Pusat Pengajian Kejuruteraan Kimia
Published: (2011)

Vasculitis in Cystic Fibrosis
by: Francesca Sposito, et al.
Published: (2020-11-01)

Nutritional Care in Children with Cystic Fibrosis
by: Elena Mariotti Zani, et al.
Published: (2023-01-01)

Cystic fibrosis transmembrane conductance regulator (CFTR)-targeted therapeutics for cystic fibrosis
by: Veselu, D-F, et al.
Published: (2024)

Aspergillus Species in Bronchiectasis: Challenges in the Cystic Fibrosis and Non-cystic Fibrosis Airways
by: Chotirmall, Sanjay Haresh, et al.
Published: (2017)

Oxidative Stress Biomarkers in Cystic Fibrosis and Cystic Fibrosis-Related Diabetes in Children: A Literature Review
by: Anca Daniela Pinzaru, et al.
Published: (2023-09-01)

Essential Fatty Acid Deficiency in Cystic Fibrosis Disease Progression: Role of Genotype and Sex
by: Nirajan Shrestha, et al.
Published: (2022-11-01)

Recent concepts on cystic fibrosis Fibrosis quística
by: William Parra
Published: (1991-01-01)

Pancreas and islet morphology in cystic fibrosis: clues to the etiology of cystic fibrosis-related diabetes
by: Sarah S. Malik, et al.
Published: (2023-11-01)

Psychometric properties of the persian version of cystic fibrosis questionnaire: Revised in children with cystic fibrosis
by: Naser Havaei, et al.
Published: (2023-01-01)

An Innovative Lipidomic Workflow to Investigate the Lipid Profile in a Cystic Fibrosis Cell Line
by: Michele Dei Cas, et al.
Published: (2020-05-01)

Airway inflammation accelerates pulmonary exacerbations in cystic fibrosis
by: Theodore G. Liou, et al.
Published: (2024-03-01)

Defects of secretion in cystic fibrosis /
by: Schultz, Carsten
Published: (2005)

Cystic Fibrosis in Malaysian Children
by: Norzila, M.Z., et al.
Published: (2005)

Lung Microbiome in Cystic Fibrosis
by: Filippo Scialo, et al.
Published: (2021-01-01)

Genome Editing for Cystic Fibrosis
by: Guoshun Wang
Published: (2023-06-01)

Clinical Advances in Cystic Fibrosis
by: Esther Imperlini, et al.
Published: (2022-10-01)

Growth factors in cystic fibrosis
by: Negar Khalighi, et al.
Published: (2016-01-01)

Future therapies for cystic fibrosis
by: Lucy Allen, et al.
Published: (2023-02-01)

Management of pregnancy in cystic fibrosis
by: Kristina Montemayor, et al.
Published: (2022-06-01)

Cystic fibrosis and the role of the physiotherapist
by: Anne Miot, et al.
Published: (1981-09-01)

Probiotics Administration in Cystic Fibrosis: What Is the Evidence?
by: Susanna Esposito, et al.
Published: (2022-07-01)

Paediatric Thoracic Imaging in Cystic Fibrosis in the Era of Cystic Fibrosis Transmembrane Conductance Regulator Modulation
by: Patrick W. O’Regan, et al.
Published: (2024-02-01)

What the future holds: cystic fibrosis and aging
by: Sydney Blankenship, et al.
Published: (2024-01-01)

A first-year dornase alfa treatment impact on clinical parameters of patients with cystic fibrosis: the Brazilian cystic fibrosis multicenter study
by: Tatiana Rozov, et al.
Published: (2013-12-01)

Evaluation of Home Medication Reconciliation by Clinical Pharmacists for Adult and Pediatric Cystic Fibrosis Patients
by: Jessica M. Louie, et al.
Published: (2018-08-01)

Cystic fibrosis modulator therapy can reverse cystic bronchiectasis
by: Peter G. Middleton, et al.
Published: (2023-07-01)

Gene therapy of cystic fibrosis: plasmid DNA contribution on in vivo lipid-based transfection efficacy
by: Lindberg, M, et al.
Published: (2011)

Changes in Essential Fatty Acids and Ileal Genes Associated with Metabolizing Enzymes and Fatty Acid Transporters in Rodent Models of Cystic Fibrosis
by: Nirajan Shrestha, et al.
Published: (2023-04-01)

Anti-Inflammatory Influences of Cystic Fibrosis Transmembrane Conductance Regulator Drugs on Lung Inflammation in Cystic Fibrosis
by: Kiera H. Harwood, et al.
Published: (2021-07-01)

Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Ubiquitylation as a Novel Pharmaceutical Target for Cystic Fibrosis
by: Ryosuke Fukuda, et al.
Published: (2020-04-01)

Lung Inflammatory Genes in Cystic Fibrosis and Their Relevance to Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapies
by: Annalucia Carbone, et al.
Published: (2023-10-01)

Cystic fibrosis autoantibody signatures associate with Staphylococcus aureus lung infection or cystic fibrosis-related diabetes
by: Ruchi Yadav, et al.
Published: (2023-09-01)